The World Health Organization (WHO) added four anti-tuberculosis medicines on Friday to its list of prequalified products. Manufactured by the generic producer MacLeods of India, these medicines will increase the choice of quality products available to procurement agencies to tackle the disease, the UN agency said in a statement.
